Equities

Star Health and Allied Insurance Company Ltd

STARHEALTH:NSI

Star Health and Allied Insurance Company Ltd

Actions
FinancialsLife Insurance
  • Price (INR)618.60
  • Today's Change12.60 / 2.08%
  • Shares traded1.04m
  • 1 Year change-0.86%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 11:29 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in INRIncome statement in INRView more

Year on year Star Health and Allied Insurance Company Ltd grew revenues 15.52% from 112.73bn to 130.23bn while net income improved 36.60% from 6.19bn to 8.45bn.
Gross margin--
Net profit margin6.22%
Operating margin4.98%
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in INRView more

In 2024, Star Health and Allied Insurance Company Ltd increased its cash reserves by 54.18%, or 1.56bn. The company earned 13.10bn from its operations for a Cash Flow Margin of 10.06%. In addition the company generated 229.73m cash from financing while 11.77bn was spent on investing.
Cash flow per share--
Price/Cash flow per share--
Book value per share--
Tangible book value per share--
More ▼

Balance sheet in INRView more

Star Health and Allied Insurance Company Ltd uses little or no debt in its capital structure.
Current ratio--
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼

Growth rates in INR

Year on year, growth in earnings per share excluding extraordinary items increased 36.31%. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
EPS growth(5 years)34.81
EPS (TTM) vs
TTM 1 year ago
26.09
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.